Second ‐generation of temporary implantable nitinol device for the relief of lower urinary tract symptoms due to benign prostatic hyperplasia: results of a prospective, multicentre study at 1 year of follow‐up

ConclusioniTIND implantation is feasible, safe and effective in providing relief of BPH ‐related symptoms, at least until 12 months postoperatively. Sexual and ejaculatory functions are fully preserved. Further studies with a longer follow‐up period are needed to assess the durability of these results and to clearly define the indications for iTIND implantation.

Source: BJU International - November 28, 2018 Category: Urology & Nephrology Authors: Francesco Porpiglia, Cristian Fiori, Daniele Amparore, Gregor Kadner, Arya Manit, Massimo Valerio, Lumen Nicolaas, Brian S. H. Ho, Sergio Alonso, Claude Schulman, Neil Barber Tags: Original Article Source Type: research